Raleigh, NC, United States of America

Julie Dickson Witzel



Average Co-Inventor Count = 2.0

ph-index = 1


Location History:

  • Arlington Heights, IL (US) (2008 - 2010)
  • Raleigh, NC (US) (2006 - 2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Julie Dickson Witzel

Introduction

Julie Dickson Witzel is a prominent inventor based in Raleigh, NC (US). She has made significant contributions to the field of biotechnology, particularly in the study of potassium channel proteins. With a total of 4 patents, her work has advanced our understanding of these essential proteins.

Latest Patents

Witzel's latest patents include groundbreaking inventions related to Slo2 and Slo4, which are novel potassium channel proteins derived from the human brain. These inventions provide isolated nucleic acid and amino acid sequences of Slo2 and Slo4, which are members of the Slo family of potassium channel proteins, also known as 'maxi' or BK potassium channel proteins. Additionally, her patents include antibodies to Slo2 and Slo4, methods for detecting these proteins, and techniques for screening potassium channel activators and inhibitors using biologically active Slo2 and Slo4. Furthermore, she has developed kits for screening activators and inhibitors of voltage-gated potassium channels that comprise Slo2 and Slo4.

Career Highlights

Witzel is currently associated with Icagen, Inc., where she continues to innovate and contribute to the field of biotechnology. Her work has been instrumental in advancing research on potassium channels, which play a crucial role in various physiological processes.

Collaborations

One of her notable collaborators is Timothy James Jegla, with whom she has worked on various projects related to her patents and research.

Conclusion

Julie Dickson Witzel's contributions to the field of biotechnology through her patents on potassium channel proteins have made a significant impact. Her innovative work continues to pave the way for advancements in medical research and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…